Follow on Google News Industry News * Regulatory * More Industries... News By Place Country(s) Industry News
Follow on Google News | Leading Regulatory Bodies, Pharmaceutical and Biotech Companies Address the Challenges Facing TodayLONDON - Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010.
By: IQPC Ltd Hear from three key regulatory experts, including: • JW McBlane, Preclinical Assessor, Clinical Trials Unit, MHRA • Dr Christen Steffen, Head of Preclinical Unit, BfArM • Dr Walter Janssens, Senior Preclinical Assessor, Preauthorisation, Coordinator Early Phase Development, Federal Agency for Medicines and Health Products, Belgium As well as Pharma & Biotech experts, including: • Dr Paul Passier, Global Clinical Pharmacology Lead, Pain, Astellas • Birgitte Søgaard, Divisional Director – Clinical Pharmacology & Translational Medicine, H. Lundbeck A/S • Michael- • Jurgen Moll, R&D Oncology, Cell Biology, Nerviano Medical Sciences • Dr James Dow, Director of Clinical Pharmacology and DMPK, (OSI) Prosidion As they discuss the following important topics: 1. The most effective trial design methodologies to ensure rapid submission and approval timelines, with innovative solutions to combining phase I and IIa from NicOx and Novartis 2. Utilise preclinical data analysis: including PK/PD modelling, metabolomics and translational methods to improve FIM predictions and avoid errors. Share best practice with discussions and case studies from UCB, Lundbeck, Servier and Johnson & Johnson 3. Increase productivity and minimise costs through implementing patient-based phase I trials: enhancing the selection and recruitment processes and overcoming operational constraints 4. Streamline the outsourcing process and establishing an effective working relationships with CROs: case study and discussion from Actelion Innovation in Phase 1 Clinical Development will also feature a unique opportunity to get up to date on the latest regulations for submission criteria, application processes and exploratory trials with case studies and a joint workshop from MHRA, BfArM and FAGGS For more information on the Phase 1 Conference you can review the agenda at http://www.phase1clinicaldevelopment.com/ About IQPC: IQPC (www.iqpc.com) End
Account Email Address Disclaimer Report Abuse
|
|